Log In
BCIQ
Print this Print this
 

JNJ-47910382

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic Hepatitis C virus (HCV) infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today